Why we need continuous pharmaceutical manufacturing and how to make it happen: a summary of thoughts from the international symposium on continuous manufacturing

Clive Badman, Charles L. Cooney, Robert T. Haslam, Alastair Florence, Konstantin Konstantinov, Markus Krumme, Salvatore Mascia, Moheb Nasr, Bernhardt L. Trout, Raymond F. Baddour

Research output: Contribution to journalArticle

Abstract

We make the case for why continuous pharmaceutical manufacturing is essential, what the barriers are, and how to overcome them. To overcome them, government action is needed in terms of tax incentives or regulatory incentives that affect time.

LanguageEnglish
Pages3521-3523
Number of pages3
JournalJournal of Pharmaceutical Sciences
Volume108
Issue number11
Early online date2 Aug 2019
DOIs
Publication statusE-pub ahead of print - 2 Aug 2019

Fingerprint

Motivation
Taxes
Pharmaceutical Preparations

Keywords

  • continuous manufacturing
  • pharmaceutical manufacturing
  • pharmaceutical technology

Cite this

Badman, Clive ; Cooney, Charles L. ; Haslam, Robert T. ; Florence, Alastair ; Konstantinov, Konstantin ; Krumme, Markus ; Mascia, Salvatore ; Nasr, Moheb ; Trout, Bernhardt L. ; Baddour, Raymond F. / Why we need continuous pharmaceutical manufacturing and how to make it happen : a summary of thoughts from the international symposium on continuous manufacturing. In: Journal of Pharmaceutical Sciences. 2019 ; Vol. 108, No. 11. pp. 3521-3523.
@article{59ab93a75ed142bd8cc1be283289a00d,
title = "Why we need continuous pharmaceutical manufacturing and how to make it happen: a summary of thoughts from the international symposium on continuous manufacturing",
abstract = "We make the case for why continuous pharmaceutical manufacturing is essential, what the barriers are, and how to overcome them. To overcome them, government action is needed in terms of tax incentives or regulatory incentives that affect time.",
keywords = "continuous manufacturing, pharmaceutical manufacturing, pharmaceutical technology",
author = "Clive Badman and Cooney, {Charles L.} and Haslam, {Robert T.} and Alastair Florence and Konstantin Konstantinov and Markus Krumme and Salvatore Mascia and Moheb Nasr and Trout, {Bernhardt L.} and Baddour, {Raymond F.}",
year = "2019",
month = "8",
day = "2",
doi = "10.1016/j.xphs.2019.07.016",
language = "English",
volume = "108",
pages = "3521--3523",
journal = "Journal of Pharmaceutical Sciences",
issn = "0022-3549",
number = "11",

}

Why we need continuous pharmaceutical manufacturing and how to make it happen : a summary of thoughts from the international symposium on continuous manufacturing. / Badman, Clive; Cooney, Charles L.; Haslam, Robert T.; Florence, Alastair; Konstantinov, Konstantin; Krumme, Markus; Mascia, Salvatore; Nasr, Moheb; Trout, Bernhardt L.; Baddour, Raymond F.

In: Journal of Pharmaceutical Sciences, Vol. 108, No. 11, 30.11.2019, p. 3521-3523.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Why we need continuous pharmaceutical manufacturing and how to make it happen

T2 - Journal of Pharmaceutical Sciences

AU - Badman, Clive

AU - Cooney, Charles L.

AU - Haslam, Robert T.

AU - Florence, Alastair

AU - Konstantinov, Konstantin

AU - Krumme, Markus

AU - Mascia, Salvatore

AU - Nasr, Moheb

AU - Trout, Bernhardt L.

AU - Baddour, Raymond F.

PY - 2019/8/2

Y1 - 2019/8/2

N2 - We make the case for why continuous pharmaceutical manufacturing is essential, what the barriers are, and how to overcome them. To overcome them, government action is needed in terms of tax incentives or regulatory incentives that affect time.

AB - We make the case for why continuous pharmaceutical manufacturing is essential, what the barriers are, and how to overcome them. To overcome them, government action is needed in terms of tax incentives or regulatory incentives that affect time.

KW - continuous manufacturing

KW - pharmaceutical manufacturing

KW - pharmaceutical technology

UR - https://www.sciencedirect.com/journal/journal-of-pharmaceutical-sciences

U2 - 10.1016/j.xphs.2019.07.016

DO - 10.1016/j.xphs.2019.07.016

M3 - Article

VL - 108

SP - 3521

EP - 3523

JO - Journal of Pharmaceutical Sciences

JF - Journal of Pharmaceutical Sciences

SN - 0022-3549

IS - 11

ER -